EDSA
Income statement / Annual
Last year (2024), Edesa Biotech, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Edesa Biotech, Inc.'s net income was -$6.17 M.
See Edesa Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$328,801.00
|
$410,870.00
|
$211,849.00
|
$228,287.00
|
$1.27 M
|
$758,689.00
|
| Cost of Revenue |
$0.00 |
$183,471.00 |
$118,188.00 |
$118,788.00 |
$17,601.00 |
$101,286.00 |
$445,320.00 |
$534,453.00 |
$1.13 M |
$840,247.00 |
| Gross Profit |
$0.00 |
-$183,471.00 |
-$118,188.00 |
-$118,788.00 |
$311,200.00 |
$309,584.00 |
-$233,471.00 |
-$306,166.00 |
$143,861.00 |
-$81,558.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0.95 |
0.75 |
-1.1 |
-1.34 |
0.11 |
-0.11 |
| Research and Development
Expenses |
$2.88 M
|
$4.79 M
|
$13.34 M
|
$17.95 M
|
$3.33 M
|
$1.10 M
|
$2.09 M
|
$1.97 M
|
$1.73 M
|
$1.03 M
|
| General & Administrative
Expenses |
$4.13 M
|
$4.43 M
|
$5.04 M
|
$5.73 M
|
$3.38 M
|
$2.05 M
|
$2.76 M
|
$2.94 M
|
$3.32 M
|
$3.23 M
|
| Selling & Marketing
Expenses |
$0.00
|
-$183,471.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$4.13 M
|
$4.24 M
|
$5.04 M
|
$5.73 M
|
$3.38 M
|
$2.05 M
|
$2.76 M
|
$2.94 M
|
$3.32 M
|
$3.23 M
|
| Other Expenses |
$0.00 |
$0.00 |
-$780,257.00 |
-$10.34 M |
$37,412.00 |
$0.00 |
$0.00 |
$0.00 |
$24,632.00 |
$0.00 |
| Operating Expenses |
$7.01 M |
$9.22 M |
$17.59 M |
$13.34 M |
$6.71 M |
$3.14 M |
$4.84 M |
$4.92 M |
$5.05 M |
$4.26 M |
| Cost And Expenses |
$7.01 M |
$9.22 M |
$17.59 M |
$13.34 M |
$6.73 M |
$3.24 M |
$5.29 M |
$5.45 M |
$6.18 M |
$5.10 M |
| Interest Income |
$153,498.00 |
$289,846.00 |
$63.52 |
$11,165.00 |
$37,778.00 |
$56,840.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$186,049.00
|
$183,471.00
|
$118,188.00
|
$118,788.00
|
$57,563.00
|
$6,371.98
|
$188,372.00
|
$179,322.00
|
$149,565.00
|
$159,521.00
|
| EBITDA |
-$6.13 M
|
-$8.19 M
|
-$17.43 M
|
-$13.22 M
|
-$6.35 M
|
-$2.83 M
|
-$4.85 M
|
-$4.85 M
|
-$4.87 M
|
-$2.65 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
-19.47 |
-6.88 |
-23.27 |
-22.95 |
-3.64 |
-7.53 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
-19.47
|
-6.89
|
-23.97
|
-22.89
|
-3.86
|
-5.72
|
| Total Other
Income/Expenses Net |
$845,499.00
|
$849,143.00
|
$822,666.00
|
$10.34 M
|
$37,412.00
|
-$309,445.00
|
$40,101.00
|
$194,698.00
|
-$110,524.00
|
$1.53 M
|
| Income Before Tax |
-$6.17 M |
-$8.37 M |
-$17.55 M |
-$13.34 M |
-$6.36 M |
-$2.78 M |
-$5.04 M |
-$5.03 M |
-$5.02 M |
-$2.81 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
-19.35
|
-6.76
|
-23.78
|
-22.03
|
-3.95
|
-3.7
|
| Income Tax Expense |
$800.00 |
$800.00 |
$800.00 |
$800.00 |
$800.00 |
-$55,404.00 |
$800.00 |
$800.00 |
$7,200.00 |
$36,800.00 |
| Net Income |
-$6.17 M |
-$8.37 M |
-$17.55 M |
-$13.34 M |
-$6.36 M |
-$2.72 M |
-$5.04 M |
-$5.03 M |
-$5.03 M |
-$2.84 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
-19.36 |
-6.62 |
-23.79 |
-22.04 |
-3.95 |
-3.75 |
| EPS |
-1.93 |
-2.93 |
-8.37 |
-7.74 |
-5.18 |
-4.15 |
-10.54 |
-218.72 |
-23.92 |
-15.01 |
| EPS Diluted |
-1.93 |
-2.93 |
-8.37 |
-7.73 |
-5.18 |
-4.15 |
-10.54 |
-211.28 |
-23.92 |
-15.01 |
| Weighted Average Shares
Out |
$3.20 M
|
$2.86 M
|
$2.10 M
|
$1.73 M
|
$1.23 M
|
$655,000.00
|
$478,229.00
|
$23,000.00
|
$210,150.00
|
$189,451.00
|
| Weighted Average Shares
Out Diluted |
$3.20 M
|
$2.86 M
|
$2.10 M
|
$1.73 M
|
$1.23 M
|
$655,318.00
|
$478,229.00
|
$23,810.00
|
$210,150.00
|
$189,451.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
